探索性分析的身体组成与专辑蛋白结合的帕克利塔塞尔诱导的外围神经病变之间的关联
Ying Jiang1, Jiayuan Guo1, Juan Zhao1
1Department of Medical Oncology, Ordos Central Hospital, Ordos, Inner Mongolia, China.
Frontiers in pharmacology
|February 23, 2026
概括
肉症是一种肌肉损失的情况,在接受nab-paclitaxel (nab-PTX) 的患者中显著增加了化疗诱导的周围神经病变 (CIPN) 的风险和严重程度. 这可能是由于在sarcopenic患者中,nab-PTX的有效剂量较高.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 身体组成分析 身体成分分析
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是一种常见的剂量限制性毒性.
- 结合白蛋白的帕克利塔塞尔 (nab-PTX) 被广泛用于各种恶性瘤.
- 骨肌肉质量在CIPN发育中的作用尚未完全理解.
研究的目的:
- 调查L3骨肌指数 (L3SMI) 与CIPN发生率和严重程度之间的关联.
- 评估L3SMI对癌症患者的NAB-PTX药理学的影响.
主要方法:
- 对52名癌症患者的回顾性分析,这些患者接受了基于NAB-PTX的化疗.
- 在第三次化疗周期之前评估L3SMI和CIPN.
- 根据L3SMI.根据sarcopenia和non-sarcopenia组进行分类.
主要成果:
- 与非sarcopenic患者相比,在sarcopenic患者中观察到较高的CIPN (≥等级B) 发病率 (P=0.042).
- 麻症患者每公斤瘦肉体重 (P<0.001) 接受了显著更高的nab-PTX剂量 (P<0.001).
- 在L3SMI和血液中药物度之间没有发现显著的相关性.
结论:
- 萨科佩尼亚是纳布-PTX治疗的患者中CIPN发病率和严重性增加的重要危险因素.
- 较高的有效纳布-PTX剂量每瘦体质可能会导致萨尔科佩尼患者的CIPN增加.
- 身体成分评估和潜在的剂量个性化对于在肉患者中管理CIPN至关重要.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
491
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
491
Peripheral Artery Disease IV: Nursing Management
437
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
437
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
289
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
289
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
491
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
491


